(Q41644134)

6 October 2017

A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal Meningitis (English)

1 reference

https://api.crossref.org/works/10.1056/NEJM197907193010303

17 May 2023

1 reference

1 reference

1 reference

J. E. Bennett

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A449951

17 May 2023

W. E. Dismukes

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A449951

17 May 2023

R. J. Duma

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A449951

17 May 2023

G. Medoff

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A449951

17 May 2023

M. A. Sande

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A449951

17 May 2023

H. Gallis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A449951

17 May 2023

J. Leonard

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A449951

17 May 2023

B. T. Fields

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A449951

17 May 2023

M. Bradshaw

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A449951

17 May 2023

H. Haywood

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A449951

17 May 2023

Z. A. McGee

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A449951

17 May 2023

T. R. Cate

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A449951

17 May 2023

C. G. Cobbs

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A449951

17 May 2023

J. F. Warner

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A449951

17 May 2023

D. W. Alling

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A449951

17 May 2023

language of work or name

English

0 references

publication date

1 July 1979

1 reference

6 October 2017

19 July 1979

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=449951

full work available at URL

17 May 2023

http://www.nejm.org/doi/pdf/10.1056/NEJM197907193010303

1 reference

https://api.crossref.org/works/10.1056/NEJM197907193010303

The New England Journal of Medicine

17 May 2023

published in

1 reference

6 October 2017

301

1 reference

6 October 2017

126-131

1 reference

6 October 2017

3

1 reference

DIAGNOSTIC AND PROGNOSTIC VALUE OF CLINICAL AND LABORATORY FINDINGS IN CRYPTOCOCCAL MENINGITIS, A FOLLOW-UP STUDY OF FORTY PATIENTS

6 October 2017

1

1 reference

https://api.crossref.org/works/10.1056/NEJM197907193010303

The improved prognosis of cryptococcal meningitis with amphotericin B therapy

17 May 2023

2

1 reference

https://api.crossref.org/works/10.1056/NEJM197907193010303

Amphotericin B in cryptococcal meningitis. Long-term results of treatment

17 May 2023

3

1 reference

https://api.crossref.org/works/10.1056/NEJM197907193010303

17 May 2023

Flucytosine

4

1 reference

https://api.crossref.org/works/10.1056/NEJM197907193010303

Synergistic Action of Amphotericin B and 5-Fluorocytosine Against Yeast-Like Organisms

17 May 2023

5

1 reference

https://api.crossref.org/works/10.1056/NEJM197907193010303

The Combined Effect of 5-Fluorocytosine and Amphotericin B in the Therapy of Murine Cryptococcosis

17 May 2023

6

1 reference

https://api.crossref.org/works/10.1056/NEJM197907193010303

Therapy of Cryptococcosis with a Combination of Flucytosine and Amphotericin B

17 May 2023

7

1 reference

https://api.crossref.org/works/10.1056/NEJM197907193010303

Treatment of disseminated mycotic infectioons. A new approach to amphotericin B therapy

17 May 2023

8

1 reference

https://api.crossref.org/works/10.1056/NEJM197907193010303

Pharmacokinetic Studies on the Oral Antimycotic Agent 5-Fluorocytosine in Individuals with Normal and Impaired Kidney Function

17 May 2023

9

1 reference

https://api.crossref.org/works/10.1056/NEJM197907193010303

Variables influencing susceptibility testing of Cryptococcus neoformans to 5-fluorocytosine

17 May 2023

10

1 reference

https://api.crossref.org/works/10.1056/NEJM197907193010303

Pharmacological Studies with 5-Fluorocytosine

17 May 2023

11

1 reference

https://api.crossref.org/works/10.1056/NEJM197907193010303

Bone marrow toxicity associated with 5-fluorocytosine therapy

17 May 2023

12

1 reference

https://api.crossref.org/works/10.1056/NEJM197907193010303

Evidence for conversion of 5-fluorocytosine to 5-fluorouracil in humans: possible factor in 5-fluorocytosine clinical toxicity

17 May 2023

14

1 reference

https://api.crossref.org/works/10.1056/NEJM197907193010303

Prognostic factors in cryptococcal meningitis. A study in 111 cases

17 May 2023

15

1 reference

https://api.crossref.org/works/10.1056/NEJM197907193010303

17 May 2023

Identifiers

1 reference

6 October 2017

1 reference